Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
出版年份 2021 全文链接
标题
Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
作者
关键词
-
出版物
ONCOLOGIST
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-08-11
DOI
10.1002/onco.13931
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiac Troponin I and T in Checkpoint Inhibitor–associated Myositis and Myocarditis
- (2021) Edmond Ang et al. JOURNAL OF IMMUNOTHERAPY
- Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome
- (2021) Demis N. Lipe et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review
- (2021) Shujing Liang et al. Frontiers in Immunology
- Myositis and myasthenia during nivolumab administration for advanced lung cancer
- (2020) Antonello Veccia et al. ANTI-CANCER DRUGS
- Immunomodulatory Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis: Pathway Toward Precision-Based Therapy
- (2020) Dinu Valentin Balanescu et al. CARDIOVASCULAR PATHOLOGY
- NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
- (2020) John A. Thompson et al. Journal of the National Comprehensive Cancer Network
- Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
- (2020) Nicolas Palaskas et al. Journal of the American Heart Association
- Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report
- (2020) Gabrielle Lie et al. Translational Lung Cancer Research
- Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma
- (2020) Qian Xing et al. Annals of Translational Medicine
- Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
- (2020) Yves Allenbach et al. AUTOIMMUNITY REVIEWS
- Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade
- (2020) Raluca Tomoaia et al. EUROPEAN JOURNAL OF CANCER
- Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
- (2020) Laura Díez-Porras et al. Scientific Reports
- Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
- (2020) Yi-Te Huang et al. Frontiers in Neurology
- A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma
- (2020) Hotaka Matsui et al. International Heart Journal
- Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors
- (2020) Jeffrey Aldrich et al. Arthritis & Rheumatology
- Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review
- (2019) Hiroko Kadota et al. Current Rheumatology Reports
- PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis
- (2019) Hayato So et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab
- (2019) S. D. Saibil et al. Current Oncology
- Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review
- (2019) Richeek Pradhan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
- (2019) Thomopoulou Konstantina et al. LUNG CANCER
- Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation
- (2019) Rafael Valenti-Azcarate et al. NEUROMUSCULAR DISORDERS
- Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
- (2019) Houssein Safa et al. Journal for ImmunoTherapy of Cancer
- Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern
- (2019) Ana Matas-García et al. AUTOIMMUNITY REVIEWS
- Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab
- (2018) Shogo Yamaguchi et al. CANADIAN JOURNAL OF CARDIOLOGY
- Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab
- (2018) Fadi Nasr et al. EUROPEAN JOURNAL OF CANCER
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- PD-1 Inhibitor-associated Myopathies
- (2018) Teerin Liewluck et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Myositis as an adverse event of immune checkpoint blockade for cancer therapy
- (2018) Mohsin Shah et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity
- (2018) Nicolas Martinez-Calle et al. HAEMATOLOGICA
- Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti–programmed death 1 antibody
- (2018) T. Shirai et al. EUROPEAN JOURNAL OF CANCER
- Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
- (2018) Alvaro Moreira et al. EUROPEAN JOURNAL OF CANCER
- Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
- (2018) Cecilia Monge et al. Journal for ImmunoTherapy of Cancer
- Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings
- (2018) Ryosuke Imai et al. Journal of Thoracic Oncology
- Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
- (2016) Nico Melzer et al. JOURNAL OF NEUROLOGY
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- PRISMA harms checklist: improving harms reporting in systematic reviews
- (2016) Liliane Zorzela et al. BMJ-British Medical Journal
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search